Esperion Names Sheldon Koenig President, CEO
ANN ARBOR—Esperion Therapeutics Inc. announced the appointment of Sheldon Koenig as president, CEO, and board member, effective immediately. He succeeds Tim Mayleben, whom company officials said “decided to step down” after a decade as the company’s CEO. Mayleben will continue to serve as a senior advisor “to help ensure a smooth transition,” company officials said







